Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs
Open Access
- 23 June 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (1) , 223-234
Abstract
BACKGROUND AND PURPOSE In rodents, the endothelial KCa channels, KCa3.1 and KCa2.3, have been shown to play a crucial role in initiating endothelium‐derived hyperpolarizing factor (EDHF) vasodilator responses. However, it is not known to what extent these channels are involved in blood pressure regulation in large mammals, which would also allow us to address safety issues. We therefore characterized canine endothelial KCa3.1 and KCa2.3 functions and evaluated the effect of the KCa3.1/KCa2.3 activator SKA‐31 on blood pressure and heart rate in dogs.EXPERIMENTAL APPROACH Canine endothelial KCa3.1/KCa2.3 functions were studied by patch‐clamp electrophysiology and wire myography in mesenteric arteries. Systemic cardiovascular actions of acute SKA‐31 administration were monitored in conscious, unstressed beagle dogs.KEY RESULTS Mesenteric endothelial cells expressed functional KCa3.1 and KCa2.3 channels that were strongly activated by SKA‐31. SKA‐31 hyperpolarized the endothelial membrane and doubled endothelial hyperpolarization‐dependent vasodilator responses in mesenteric arteries. SKA‐31 (2 mg·kg−1, i.v.) rapidly decreased the MAP by 28 ± 6 mmHg; this response was transient (8 ± 1 s), and the initial drop was followed by a fast and pronounced increase in HR (+109 ± 7 beats min−1) reflecting baroreceptor activation. SKA‐31 significantly augmented similar transient depressor responses elicited by ACh (20 ng·kg−1) and doubled the magnitude of the response over time.CONCLUSIONS AND IMPLICATIONS Activation of endothelial KCa3.1 and KCa2.3 lowers arterial blood pressure in dogs by an immediate electrical vasodilator mechanism. The results support the concept that pharmacological activation of these channels may represent a potential unique endothelium‐specific antihypertensive therapy.Keywords
This publication has 40 references indexed in Scilit:
- Effects on Atrial Fibrillation in Aged Hypertensive Rats by Ca 2+ -Activated K + Channel InhibitionHypertension, 2011
- Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+-activated K+-channelsActa Physiologica, 2010
- Cardiac Small Conductance Ca 2+ -Activated K + Channel Subunits Form Heteromultimers via the Coiled-Coil Domains in the C Termini of the ChannelsCirculation Research, 2010
- NS309 restores EDHF‐type relaxation in mesenteric small arteries from type 2 diabetic ZDF ratsBritish Journal of Pharmacology, 2010
- Vascular KCa-channels as therapeutic targets in hypertension and restenosis diseaseExpert Opinion on Therapeutic Targets, 2010
- Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization?Journal of Molecular and Cellular Cardiology, 2009
- Upregulation of intermediate calcium-activated potassium channels counterbalance the impaired endothelium-dependent vasodilation in stroke-prone spontaneously hypertensive ratsTranslational Research, 2009
- EF hands at the N-lobe of calmodulin are required for both SK channel gating and stable SK–calmodulin interactionJournal of General Physiology, 2009
- EDHF: an updateClinical Science, 2009
- Endothelial Ca2+‐activated K+channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discoveryBritish Journal of Pharmacology, 2009